Kim, R D
Alberts, S R
Peña, C
Genvresse, I
Ajavon-Hartmann, A
Xia, C
Kelly, A
Grilley-Olson, J E
Article History
Received: 8 August 2017
Revised: 2 November 2017
Accepted: 7 November 2017
First Online: 18 January 2018
Competing interests
: RDK reports grants and personal fees from Bayer and Bristol-Myers Squibb, personal fees from Lilly and grants from Eisai. JEG-O reports institutional clinical trial support from Bayer, Novartis, Peregrine Pharmaceuticals, NanoCarrier, Genentech, Seattle Genetics, MedImmune and Pfizer. CP, CX and AK are employees of Bayer HealthCare. IG and AA-H are employees of Bayer AG. SRA declares no competing financial interest.